Every one of those 1 sits in a single category, markets. Dr Lal PathLabs is most often covered alongside Aditya Infotech, which appears in 1 of these 1 story. Dr Lal PathLabs appears in 1 tracked Finance story from August 20, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dr Lal PathLabs
Every one of those 1 sits in a single category, markets. Dr Lal PathLabs is most often covered alongside Aditya Infotech, which appears in 1 of these 1 story. Dr Lal PathLabs appears in 1 tracked Finance story from August 20, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 14 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dr Lal PathLabs. Shared-story counts are live from our verified record — not editorial picks.
BSE's MSCI index agreement could open an onshore F&O route, while RBI's approval lets LIC lift its HDFC Bank stake to 9.99%. Aditya Infotech's ₹1,500 crore equity raise and Titagarh's Indian Railways traction-motor approval add mid-cap catalysts to a busy August 20 session.